This test is intended to be used as an aid in the diagnosis of both human granulocytic anaplasmosis (HGA), formerly known as human granulocytic ehrlichiosis (HGE), caused by Anaplasma phagocytophilum and human monocytic ehrlichiosis (HME) caused by Ehrlichia chaffeensis.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the Food and Drug Administration.